Novel pharmaceutical composition for preventing and treating anthracnose of citrus

A technology of citrus anthracnose and composition, which is applied in the field of citrus disease prevention, can solve the problems of general taste and appearance color, low citrus yield and sugar content rate, etc., and achieves benefits for popularization and application, low cost, increased yield and content sugar effect

Inactive Publication Date: 2017-03-15
钟山县绿森农业开发有限公司
View PDF5 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] The invention provides a novel pharmaceutical composition for preventing and treating citrus anthracnose to solve the problems of increasing citrus yield, low sugar content, general taste and appearance color and the like after the use of existing drugs for preventing and treating citrus anthracnose

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0066] The preparation method of the novel pharmaceutical composition for preventing and treating citrus anthracnose comprises the following steps:

[0067] S1: Mix and pulverize purslane, mugwort leaf, tea tree leaves, pyrethrum, magnolia officinalis, neem, bitter bark vine, ailanthus, lettuce, mint, and castor to obtain mixture Ⅰ, which is added to ethanol. 1:14-16, the ultrasonic power is 200-300W, the ethanol concentration is 65%-80%, and the extraction temperature is 66-72°C, extract the medicinal solution for 18-24min to obtain the medicinal solution;

[0068] S2: passing the liquid medicine prepared in step S1 through a 3000-5000 mesh sieve to obtain a filtrate;

[0069] S3: adding potassium salt, phosphorus salt, nitrogen salt, calcium salt, magnesium salt, iodine salt, boron salt, molybdenum salt, zinc salt, manganese salt, copper salt, iron salt, vitamin, amino acid, Indolebutyric acid, gibberellin, 6-benzyl adenine, naphthaleneacetic acid, agar, kinetin, polyvinylp...

Embodiment 1

[0075] A novel pharmaceutical composition for preventing and treating citrus anthracnose, comprising the following raw materials in parts by weight: 110 parts of purslane, 100 parts of mugwort leaves, 85 parts of tea tree leaves, 85 parts of pyrethrum, 75 parts of magnolia bark, 70 parts of neem, 60 parts of bitter bark vine, 58 parts of ailanthus, 52 parts of lettuce, 50 parts of mint, 50 parts of castor, 2.5 parts of potassium salt, 2 parts of phosphorus salt, 1.5 parts of nitrogen salt, 0.8 part of calcium salt, 0.8 part of magnesium salt, iodized salt 0.3 parts, 0.3 parts of boron salts, 0.3 parts of molybdenum salts, 0.3 parts of zinc salts, 0.3 parts of manganese salts, 0.3 parts of copper salts, 0.3 parts of iron salts, 0.3 parts of vitamins, 0.2 parts of amino acids, 0.08 parts of indole butyric acid, Gibberella 0.08 parts of ketone, 0.07 parts of 6-benzyl adenine, 0.05 parts of naphthaleneacetic acid, 0.2 parts of agar, 0.05 parts of kinetin, 1.6 parts of polyvinylpyrr...

Embodiment 2

[0105] A novel pharmaceutical composition for preventing and treating citrus anthracnose, comprising the following raw materials in parts by weight: 102 parts of purslane, 96 parts of mugwort leaves, 72 parts of tea tree leaves, 76 parts of pyrethrum, 60 parts of magnolia bark, 55 parts of neem, 45 parts of bitter bark vine, 42 parts of Ailanthus sinensis, 40 parts of lettuce, 38 parts of mint, 35 parts of castor, 2 parts of potassium salt, 1 part of phosphorus salt, 1 part of nitrogen salt, 0.6 part of calcium salt, 0.6 part of magnesium salt, iodized salt 0.2 parts, 0.2 parts of boron salts, 0.2 parts of molybdenum salts, 0.2 parts of zinc salts, 0.2 parts of manganese salts, 0.2 parts of copper salts, 0.2 parts of iron salts, 0.2 parts of vitamins, 0.2 parts of amino acids, 0.06 parts of indole butyric acid, Gibberella 0.06 parts of prime, 0.06 parts of 6-benzyl adenine, 0.04 parts of naphthaleneacetic acid, 0.1 parts of agar, 0.04 parts of kinetin, 0.8 parts of polyvinylpyr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a novel pharmaceutical composition for preventing and treating the anthracnose of citrus. The novel pharmaceutical composition is prepared from the following raw materials: herba portulacae, folium artemisiae argyi, tea tree leaves, pyrethrum, mangnolia officinalis, melia azedarach, angled bittersweet, ailanthus, asparagus lettuce, mint, castor, potassium salt, phosphor salt, nitrogen salt, calcium salt, magnesium salt, iodine salt, boron salt, molybdenum salt, zinc salt, manganese salt, copper salt, iron salt, vitamins, amino acid, indolebutyric acid, gibberellins, 6-benzylaminopurine, naphthylacetic acid, agar, kinetin, polyvinylpyrrolidone, sodium methylene bis-naphthalene sulfonate, a Dupont EEA2112AC compatilizer, earthworm powder, alkyl potassium sulfate, acrylate, epoxypropoxy propyl trimethoxy silane, carrageenan and ethanol. According to the novel pharmaceutical composition for preventing and treating the anthracnose of the citrus, the yield and the sugar content can be increased, the citrus is good in taste, mellow and full in surface colors and high in quality, and the use effect is superior to that of a conventional pharmaceutical composition.

Description

[0001] 【Technical field】 [0002] The invention belongs to the technical field of citrus disease prevention, and in particular relates to a novel pharmaceutical composition for preventing and treating citrus anthracnose. [0003] 【Background technique】 [0004] Citrus (Citrus reticulata Blanco) belongs to the Rutaceae plant. It likes a warm and humid climate, and its cold resistance is slightly stronger than pomelo, lime, and sweet orange. The Rutaceae citrus subfamily is distributed at 16°-37° north latitude. It is a tropical and subtropical evergreen fruit tree (except Citrus aurantium), and there are 3 genera used for economic cultivation: Citrus Citrus, Citrus and Kumquat. The citrus cultivated in China and other countries of the world is mainly of the Citrus genus. [0005] Citrus anthracnose is the most common disease, which can occur from March to October. It can harm leaves, treetops, fruits and flowers, often causing a large number of fallen leaves, fallen flowers, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A01N65/28A01N59/26A01N59/12A01N59/08A01N59/06A01N59/02A01N59/00A01N49/00A01N45/02A01N43/90A01N43/78A01N43/38A01N43/36A01N43/12A01N37/44A01N37/10A01P3/00A01P21/00
CPCA01N65/00A01N37/10A01N37/44A01N43/12A01N43/36A01N43/38A01N43/78A01N43/90A01N45/02A01N49/00A01N59/00A01N59/02A01N59/06A01N59/08A01N59/12A01N59/26A01N65/28A01N2300/00
Inventor 董俊良莫亿军张燕
Owner 钟山县绿森农业开发有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products